Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Moderate quality score of 58/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant solvency concerns.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, anchored by a strong, well-covered dividend yield.
UHT demonstrates strong business quality with robust profitability and healthy margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company exhibits steady, low-single-digit revenue growth however, earnings have severely contracted over the same period. This growth is supported by elite operational efficiency, sustaining an impressive 36.3% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $74.0M | +0.2% | +3.1% | +4.9% | +4.5% | |
| EBITDA | $34.8M | — | +3.6% | — | — | |
| Net Income | $4.3M | -8.4% | -5.9% | — | -2.9% | |
| EPS (Diluted) | $0.32 | -8.6% | -6.0% | -2.1% | -3.3% | |
| Free Cash Flow | $13.9M | +4.6% | +13.9% | +3.2% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 94.4% | 94.4% | 94.5% | 94.7% |
| Operating Margin | 36.3% | 35.0% | 34.6% | 34.1% |
| Net Margin | 11.8% | 17.8% | 41.2% | 37.6% |
| FCF Margin | 33.3% | 47.5% | 44.0% | 39.5% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | — | $0.88 | — | ||
| Q1'26 | — | $0.85 | — | ||
| Q1'26 | — | $0.85 | — | ||
| Q4'25 | — | $0.88 | — | ||
| Q3'25 | — | $0.85 | — | ||
| Q2'25 | — | $0.86 | — | ||
| Q1'25 | — | $0.85 | — | ||
| Q4'24 | — | $0.82 | — |
Total return is -0.9% (1Y), lagging the benchmark by -25.9%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -1.7% | -11.0% | — |
| 1Y | -0.9% | -25.9% | +7.2% |
| 3YCAGR | -1.4% | -20.2% | +16.9% |
| 5YCAGR | -3.3% | -16.5% | +22.5% |
| 10YCAGR | +1.7% | -11.9% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Universal Health Realty Income Trust (UHT) valuation, health, and returns.
Based on peer relative multiples, Universal Health Realty Income Trust appears Cheap versus peers compared to industry peers.
Universal Health Realty Income Trust has multiple valuation anchors: Peer Relative Fair Value: $56.81. A convergence of these signals offers higher conviction.
Universal Health Realty Income Trust displays fair financial health with a composite quality score of 58/100, supported by a Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of 4.8%.
Universal Health Realty Income Trust pays a 7.8% dividend yield, covered by a 0% payout ratio with 39 years of growth, supplemented by a 0.0% buyback yield.
Universal Health Realty Income Trust's current growth trajectory is Decelerating. The company achieved +0.2% 1Y revenue growth and -8.6% 1Y EPS growth, compared to its 3Y revenue CAGR of +3.1%.
Wall Street consensus is Hold based on 1 analysts. The consensus price target represents a N/A change from current levels.
Investment risks for Universal Health Realty Income Trust include: -16.0% 1-year max drawdown. Volatility risk is characterized by a beta of 0.12x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.